Pluristem Therapeutics, Inc.

Pluristem Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Pluristem Therapeutics, Inc. is not a good value stock. Pluristem Therapeutics, Inc. is not a good growth stock. Pluristem Therapeutics, Inc. is not very popular among insiders. Pluristem Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell ther...

News